Literature DB >> 15269351

A synthetic peptide from a heptad repeat region of herpesvirus glycoprotein B inhibits virus replication.

Katsunori Okazaki1, Hiroshi Kida1.   

Abstract

Glycoprotein B (gB) is the most conserved glycoprotein of herpesviruses and plays important roles in virus infectivity. Two intervening heptad repeat (HR) sequences were found in the C-terminal half of all herpesvirus gBs analysed. A synthetic peptide derived from the HR region (aa 477-510) of bovine herpesvirus type 1 (BoHV-1) gB was studied for its ability to inhibit virus replication. The peptide interfered with cell-to-cell spread and consistently inhibited replication of BoHV-1, with a 50 % effective concentration value (EC(50)) of 5 microM. Inhibition of replication was obtained not only with herpesviruses including pseudorabies virus and herpes simplex virus type 1 but also partly with Newcastle disease virus. Possible mechanisms of membrane fusion inhibition by the peptide are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15269351     DOI: 10.1099/vir.0.80051-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Addition of a C-terminal cysteine improves the anti-herpes simplex virus activity of a peptide containing the human immunodeficiency virus type 1 TAT protein transduction domain.

Authors:  Hermann Bultmann; Jeremy Teuton; Curtis R Brandt
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

2.  Identification of functional domains in herpes simplex virus 2 glycoprotein B.

Authors:  Wei Li; Tanja J Minova-Foster; Daniel D Norton; Martin I Muggeridge
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  A heptad repeat in herpes simplex virus 1 gH, located downstream of the alpha-helix with attributes of a fusion peptide, is critical for virus entry and fusion.

Authors:  Tatiana Gianni; Laura Menotti; Gabriella Campadelli-Fiume
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.

Authors:  Radeekorn Akkarawongsa; Nina E Pocaro; Gary Case; Aaron W Kolb; Curtis R Brandt
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

Review 5.  Progress on the development of therapeutics against West Nile virus.

Authors:  Michael S Diamond
Journal:  Antiviral Res       Date:  2009-06-06       Impact factor: 5.970

6.  Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics.

Authors:  Alaa F Nahhas; Alrayan F Nahhas; Thomas J Webster
Journal:  Nanomedicine (Lond)       Date:  2021-05-14       Impact factor: 5.307

7.  Structural characteristics and antiviral activity of multiple peptides derived from MDV glycoproteins B and H.

Authors:  Xiaojia Wang; Xiaojing Chi; Ming Wang
Journal:  Virol J       Date:  2011-04-25       Impact factor: 4.099

8.  Peptide inhibitors of dengue virus and West Nile virus infectivity.

Authors:  Yancey M Hrobowski; Robert F Garry; Scott F Michael
Journal:  Virol J       Date:  2005-06-01       Impact factor: 4.099

9.  Peptide inhibitors of tembusu virus infection derived from the envelope protein.

Authors:  Dongmin Zhao; Lijiao Zhang; Kaikai Han; Qingtao Liu; Jing Yang; Xinmei Huang; Yuzhuo Liu; Yin Li; Peng Zhao
Journal:  Vet Microbiol       Date:  2020-05-07       Impact factor: 3.293

10.  Infectivity inhibition by overlapping synthetic peptides derived from the gH/gL heterodimer of herpes simplex virus type 1.

Authors:  Gianluigi Franci; Annarita Falanga; Carla Zannella; Veronica Folliero; Francesca Martora; Marilena Galdiero; Stefania Galdiero; Giancarlo Morelli; Massimiliano Galdiero
Journal:  J Pept Sci       Date:  2017-02-14       Impact factor: 1.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.